🔎 Trials Near Me

Akèy › Kansè pwostat rezistan a kastasyon › New York › New York City

Etid klinik pou Kansè pwostat rezistan a kastasyon nan New York City, NY

7 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Ap rekriteFaz 3
  • NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
  • Columbia University Medical Center, New York
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 3
  • NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Ap rekriteFaz 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 0006), New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06863272

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Ap rekriteFaz 1
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medicine, New York
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Ap rekriteFaz 1
  • Memorial Sloan Kettering Cancer Center, New York
Laj 18 ak plis · Gason · Mizajou Aug 10, 2026 · NCT06067841

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Ap rekriteFaz 1/2
  • Weill Cornell Medicine at New York-Presbyterian, New York
Laj 18 ak plis · Gason · Mizajou May 6, 2026 · NCT04868604

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 1
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Laj 18 ak plis · Gason · Mizajou Nov 21, 2025 · NCT05743621

Etid Kansè pwostat rezistan a kastasyon nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.